Trying to Tame the Wild West of Surrogacy in India
By Raksha Kumar,
AlJazeera America
| 01. 14. 2015
Untitled Document
Divya is 28, in her seventh month of pregnancy and a surrogate for an Australian couple in their 40s. (Her last name has been withheld because her family members are unaware she is a surrogate, and because of the stigma that surrogacy carries in India.) This is not the first baby Divya has carried that is not her own — there was another in 2010, for an Indian couple. She is one of the millions of surrogates who help to generate 24.8 billion rupees in revenue each year and, along with roughly 3,000 clinics that provide in vitro fertilization, have turned India into the surrogacy capital of the world.
Because surrogacy is legal but not regulated, surrogates like Divya are subject to exploitation by middlemen, clinics and would-be parents, say women's health advocates. Last month, India lost another opportunity to regulate its multimillion-dollar surrogacy industry, as the country’s Parliament failed to pass the Assisted Reproductive Technique bill, or ART, during its winter session, citing a lack of time. Critics of the bill say it doesn’t do enough...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...